CD4 and head and neck squamous cell carcinoma: Whereas in PBMC HC, CD4+ T cells made up only a small fraction of PD-L1+ T cells (7.1 ± 10.3%), the percentage highly increased in PBMC HNSCC (42.8 ± 24.4%; p < 0.0001).